Medical Marijuana and the Opioid Crisis

Published - Jul 2019| Code - HLC236A| Publisher - BCC Publishing

Report Highlights

Just in 2017, medical cannabis totaled $7.3 billion, up from $4.8 billion in 2016. This segment will likely achieve a 22.2% CAGR to reach nearly $19.8 billion at the producer level in 2022 and will account to more than 80% of the global market.

Politics aside, one must remember that marijuana is still a drug and needs to be treated as such with its potential side effects.

Even if cannabinoids-based drugs will not fully substitute opioid use, combination of medical marijuana use with reduced dose of opioid will help to curb the crisis.

Report Includes

  • Short introduction to what is medical marijuana: definition and main active compounds (cannabinoids)
  • Current uses of medical marihuana: epilepsy, inflammation,  especially as pain medication for cancer patients
  • Approved products on the market containing medical marihuana/cannabinoids
  • Current manufacturers of medical marijuana
  • Information on medical marijuana in drug development market (examples of some companies)
  • How medical marijuana is different from opioids and how/if it helps with the crisis
  • Effect of legislation on medical marijuana sector: potential trends in medical marijuana market, new opportunities and products

Analyst Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology and industrial assay development and drug manufacturing. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with different research field trends and likely future developments.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter Name Pages Price Member Price
Full Report: Medical Marijuana and the Opioid Crisis 15 $2,500 Free
Share This Report